Skip to Content

Zimmer Biomet Holdings Inc

ZBH: XSWX (CHE)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
CHF 314.77Nfgv

Revolutionary Innovations Set Some Companies Apart in Medtech

Healthcare innovation represents a key area of exponential growth, and we think the scientific community's understanding of medical interventions has increased significantly over time and is likely to continue fast-paced development during the decades ahead. Within healthcare innovation, we view two key areas of explosive growth potential: innovative therapies and innovative devices and diagnostics, the latter of which is the focus of our new research. While the medical device and diagnostic industry's innovation engine appears mostly evolutionary to us, revolutionary innovations can represent the spark that both pioneers new markets and widens economic moats through the intangible asset source that is often present in medtech. Massive growth in scientific advancements and medical articles, along with major increases in medical patents, supports exponential growth opportunities in certain pockets of the medtech industry, in our opinion.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of ZBH so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center